Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-HLA-A1-peptide (EADPTGHSY) Complex (HYB3)

Catalog #:   RHM02901 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: ELISA
Expression system: Mammalian Cells
Overview

Catalog No.

RHM02901

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Target

HLAA,Human leukocyte antigen A,HLA class I histocompatibility antigen,A alpha chain,HLA-A,MAGEA1,CT1.1,Cancer/testis antigen 1.1,MAGE1A,MAGE1,Antigen MZ2-E,Melanoma-associated antigen 1,MAGE-1 antigen

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P04439 & P43355

Applications

ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

HYB3

Data Image
References

Structural characterization and AlphaFold modeling of human T cell receptor recognition of NRAS cancer neoantigens., PMID:39576860

Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding., PMID:39122001

Uncommon P1 Anchor-featured Viral T Cell Epitope Preference within HLA-A*2601 and HLA-A*0101 Individuals., PMID:38885041

Structural characterization and AlphaFold modeling of human T cell receptor recognition of NRAS cancer neoantigens., PMID:38826362

Ocular Surface Disease as Extraesophageal Gastroesophageal Reflux Disease Manifestation: A Specific Therapeutic Strategy., PMID:37404100

Herpesvirus immunology in solid organ transplant recipients - liver transplant study (HISTORY): a retrospective and prospective observational cohort study., PMID:37024811

Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma., PMID:36847626

Precision Neoantigen Discovery Using Large-Scale Immunopeptidomes and Composite Modeling of MHC Peptide Presentation., PMID:36796642

Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases., PMID:35705369

Bispecific antibodies targeting mutant RAS neoantigens., PMID:33649101

Evaluation of potential MHC-I allele-specific epitopes in Zika virus proteins and the effects of mutations on peptide-MHC-I interaction studied using in silico approaches., PMID:33636637

Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses., PMID:32561639

Strict Assembly Restriction of Peptides from Rabbit Hemorrhagic Disease Virus Presented by Rabbit Major Histocompatibility Complex Class I Molecule RLA-A1., PMID:32522857

The HLA A03 Supertype and Several Pan Species Major Histocompatibility Complex Class I A Allotypes Share a Preference for Binding Positively Charged Residues in the F Pocket: Implications for Controlling Retroviral Infections., PMID:32075930

MHC class I allele diversity in cynomolgus macaques of Vietnamese origin., PMID:31720104

Determination of a T cell receptor of potent CD8+ T cells against simian immunodeficiency virus infection in Burmese rhesus macaques., PMID:31711644

Divergent Peptide Presentations of HLA-A*30 Alleles Revealed by Structures With Pathogen Peptides., PMID:31396224

In silico design of MHC class I high binding affinity peptides through motifs activation map., PMID:30598069

Broad CD8+ T cell cross-recognition of distinct influenza A strains in humans., PMID:30575715

In silico prediction of potential vaccine candidates on capsid protein of human bocavirus 1., PMID:29207326

Myelin Oligodendrocyte Glycoprotein and Multiple Sclerosis., PMID:28875859

Isolation of a monoclonal antibody from a phage display library binding the rhesus macaque MHC class I allomorph Mamu-A1*001., PMID:28719653

Cyclic MOG35-55 ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis., PMID:28642030

A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens., PMID:28628042

36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016., PMID:27885969

TCR-contacting residues orientation and HLA-DRβ* binding preference determine long-lasting protective immunity against malaria., PMID:27363338

Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody., PMID:27022262

Promiscuous Recognition of a Trypanosoma cruzi CD8+ T Cell Epitope among HLA-A2, HLA-A24 and HLA-A1 Supertypes in Chagasic Patients., PMID:26974162

STK39, But Not BST1, HLA-DQB1, and SPPL2B Polymorphism, Is Associated With Han-Chinese Parkinson's Disease in Taiwan., PMID:26469904

Lepidotol A from Mesua lepidota Inhibits Inflammatory and Immune Mediators in Human Endothelial Cells., PMID:26301802

Elucidating the immunological effects of 5-azacytidine treatment in patients with myelodysplastic syndrome and identifying new conditional ligands and T-cell epitopes of relevance in melanoma., PMID:26239596

Broadening the repertoire of melanoma-associated T-cell epitopes., PMID:25854582

Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates., PMID:25648131

Antigen-specific vaccines for cancer treatment., PMID:25483639

Improving the prediction of HLA class I-binding peptides using a supertype-based method., PMID:24508661

Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells., PMID:23926201

Mixed functional characteristics correlating with TCR-ligand koff -rate of MHC-tetramer reactive T cells within the naive T-cell repertoire., PMID:23893393

T-cells from HLA-B*57:01+ human subjects are activated with abacavir through two independent pathways and induce cell death by multiple mechanisms., PMID:23541086

MYCN: from oncoprotein to tumor-associated antigen., PMID:23162796

The HLA-B*5101 molecule-binding capacity to antigens used in animal models of Behçet's disease: a bioinformatics study., PMID:22953618

Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune response., PMID:22658578

Cytomegalovirus-specific CD8+ T cells targeting different peptide/HLA combinations demonstrate varying T-cell receptor diversity., PMID:22044339

Recognition of class I MHC by a rat Ly49 NK cell receptor is dependent on the identity of the P2 anchor amino acid of bound peptide., PMID:21841133

Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers., PMID:21636247

KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motif., PMID:21423672

Functional analysis of frequently expressed Chinese rhesus macaque MHC class I molecules Mamu-A1*02601 and Mamu-B*08301 reveals HLA-A2 and HLA-A3 supertypic specificities., PMID:21274527

A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy., PMID:21207413

The gastrointestinal nematode Trichostrongylus colubriformis down-regulates immune gene expression in migratory cells in afferent lymph., PMID:20950493

Modeling major histocompatibility complex binding by nonparametric averaging of multiple predictors and sequence encodings., PMID:20934429

Ensemble approaches for improving HLA class I-peptide binding prediction., PMID:20849860

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-HLA-A1-peptide (EADPTGHSY) Complex (HYB3) [RHM02901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only